Studies on the binding affinity of aminoglycoside antibiotics to the HIV-1 Rev Responsive Element for designing potential antiviral agents

Journal of Microbiology and Biotechnology

Volumn 16, Issue 1, 2006, Pages 109-117

  Kwon, Youngjoo ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Aminoglycoside antibiotics; Binding affinity to RRE; HIV 1 RRE; Inhibition of HIV 1 Rev RRE interaction; Tm

Indexed keywords

AMINOGLYCOSIDE; ANTIVIRUS AGENT; ARGININE PLUS NEAMINE PLUS PYRENE CONJUGATE; ERYTHROMYCIN; FRAMYCETIN; GENTAMICIN; KANAMYCIN B; NEAMINE; PAROMOMYCIN; REV PROTEIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; DNA RESPONSIVE ELEMENT; DRUG BINDING; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 32944478623     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871.
2. Battiste, J. L., H. Mao, S. Rao, R. Tan, D. R. Muhandiram, L. E. Kay, A. D. Frankel, and J. R. Williamson. 1996. α Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science 273: 1547-1551.
3. Battiste, J. L., R. Tan, A. D. Frankel, and J. R. Williamson. 1994. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs. Biochemistry 33: 2741-2747.
4. Calnan, B. J., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Arginine-mediated RNA recognition: The arginine fork. Science 252: 1167-1171.
5. Cho, B.-G., C.-H. Kim, B. K. Lee, and S.-H. Cho. 2005. Comparison of antibiotics resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733.
6. Cochrane, A. W., C. H. Chen, and C. A. Rosen. 1990. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87: 1198-1202.
7. Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope specific RNA localization. Cell 57: 1155-1165.
8. Felber, B. K., M. Hadzopouloucladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86: 1495-1499.
9. Greenberg, W. A., E. S. Priestley, P. S. Sears, P. B. Alper, C. Rosenbohm, M. Hendrix, S.-C. Hung, and C.-H. Wong. 1999. Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation. J. Am. Chem. Soc. 121: 6527-6541.
10. Hamasaki, K. and A. Ueno. 2001. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for RNA-protein interactions derived from HIV-1 activators. Bioorg. Med. Chem. Lett. 11: 591-594.
11. Hendrix, M., S. Priestly, G. F. Joyce, and C. H. Wong. 1997. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance. J. Am. Chem. Soc. 119: 3641-3648.
12. Hung, L.-W., E. L. Holbrook, and S. R. Holbrook. 2000. The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability. Proc. Natl. Acad. Sci. USA 97: 5107-5112.
13. Icacmpo, S. and A. Cochrane. 1996. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J. Virol. 70: 8332-8339.
14. Ippolito, J. A. and T. A. Steitz. 2000. The structure of the HIV-1 RRE high affinity Rev binding site at 1.6 Å resolution. J. Mol. Biol. 295: 711-717.
15. Kharel, M., B. Subba, H. C. Lee, K. Liou, J. S. Woo, D. H. Kim, Y.-H. Moon, and J. K. Sohng. 2003. Identification of 2-deoxy-scyllo-inosose synthase in aminoglycoside producer Streptomyces. J. Microbiol. Biotechnol. 13: 828-831.
16. Kirk, S. R., N. W. Leudtke, and Y. Tor. 2000. Neomycinacridine conjugate: A potential inhibitor of Rev-RRE binding. J. Am. Chem. Soc. 122: 980-981.
17. Lacourciere, K. A., J. T. Stivers, and P. Marino. 2000. Mechanism of neomycin and Rev peptide binding to Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy. Biochemistry 39: 5630-5641.
18. Lapidot, A., V. Vijayabaskar, A. Litovchick, J. Yu, and T. L. James. 2004. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy. FEBS Lett. 577: 415-421.
19. Luedtke, N. W., Q. Liu, and Y. Tor. 2003. RNA-ligand interactions: Affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element. Biochemistry 42: 11391-11403
20. Lynch, S. R., R. L. Gonzalez, and J. D. Puglisi. 2003. Comparison of X-ray crystal structure of the 305 subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex. Structure (Camb.) 11: 43-53.
21. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254-257.
22. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60: 675-683.
23. Mikkelsenl, N. E., K. Johansson, A. Virtanen, and L. A. Kirsebom. 2001. Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat. Struct. Biol. 8: 510-514.
24. Milligan, J. F., D. R. Groebe, G. W. Witherell, and O. C. Uhlenbeck. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15: 8793-8798.
25. Milligan, J. F. and O. C. Uhlenbeck. 1989. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180: 51-62.
26. Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247: 845-848.
27. lH NMR studies of the high-affinity Rev binding site of the Rev Responsive Element of HIV-1 mRNA: Base pairing in the core binding element. Biochemistry 33: 5357-5366.
28. Peterson, R. D. and J. Feigon. 1996. Structural change in Rev Responsive Element RNA of HIV-1 on binding Rev peptide. J. Mol. Biol. 264: 863-877.
29. Plateau, P. and M. Guéron. 1982. Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences. J. Am. Chem. Soc. 104: 7301-7311.
30. Puglish, J. D. and I. Jr. Tinoco. 1989. Absorbance melting curves of RNA. Methods Enzymol. 180: 304-325.
31. Rhee, K. Y. 2003. Purification and identification of an antifungal agent from Streptomyces sp. KH-614 antagonistic to rice blast fungus Pyricularia oryzae. J. Microbiol. Biotechnol. 13: 984-988.
32. Tok, J., L. J. Dunn, and R. C. Des Jean. 2001. Binding of dimeric aminoglycosides to the HIV-1 Rev responsive element (RRE) RNA construct. Bioog. Med. Chem. Lett. 11: 1127-1131.
33. Tuerk, C. and S. MacDougal-Waugh. 1993. In vitro evolution of functional nucleic acids: High-affinity RNA ligands of HIV-1 proteins. Gene 137: 33-39.
34. Turner, B. G. and M. F. Summers. 1998. Structural biology of HIV. J. Mol. Biol. 285: 1-32 and references therein.
35. Van Ryk, D. I. and S. Venkatesan. 1999. Real-time kinetics of HIV-1 Rev-rev responsive element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis. J. Biol. Chem. 274: 17452-17463.
36. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
37. Yoshizawa, S., D. Fourmy, and J. D. Puglisi. 1998. Structural origins of gentamycin antibiotic action. EMBO J. 17: 6437-6448.
38. Zapp, M. L. and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342: 714-716.
39. Zhao, X.-Q., K.-R. Kim, L. W. Sang, S.-H. Kang, Y.-Y. Yang, and J.-W. Suh. 2005. Genetic organization of a 50-kb gene cluster isolated from streptomyces kanamyceticus for kanamycin biosynthesis and characterization of kanamycin acetyltransferase. J. Microbiol. Biotechnol. 15: 346-353.
40. Zheng, M., H. Huang, G. K. Smith, X. Yang, and X. Gao. 1996. Genetically unstable CXG repeats are structurally dynamic and have a high propensity for folding. An NMR and UV spectroscopic study. J. Mol. Biol. 264: 323-336.